Two Sigma Securities’s Psyence Biomedical PBM Stock Holding History

Two Sigma Securities’s Portfolio PBM Stock Details PBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-260	Closed	-$7.76K	–	2174
2025 Q1	$7.76K	Buy	+260	New	+$16.5K	﹤0.01%	1261
2024 Q4	–	Sell	-4	Closed	-$1.5K	–	3419
2024 Q3	$1.5K	Buy	+4	New	+$5.41K	﹤0.01%	2708
2024 Q2	–	Sell	-15	Closed	-$63.6K	–	3787
2024 Q1	$63.6K	Buy	+15	New	+$62.6K	﹤0.01%	2539

Other funds holding PBM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

Two Sigma Securities's PBM Position: Q2 2025 in Review

Two Sigma Securities sold out of Psyence Biomedical (PBM) in Q2 2025, closing a stake of 260 shares — an estimated $7.76K sold.

Two Sigma Securities first reported a position in PBM in Q1 2024 and held it in 3 quarters. The position peaked at $63.6K in Q1 2024. 6 funds tracked by Wall St. Rank hold PBM as of Q2 2025.

Two Sigma Securities reported no remaining Psyence Biomedical position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 260 Psyence Biomedical shares in Q2 2025, an estimated $7.76K.
Two Sigma Securities first reported a position in Psyence Biomedical in Q1 2024 and held it in 3 quarters.
Two Sigma Securities's Psyence Biomedical position peaked at $63.6K in Q1 2024.
6 funds tracked by Wall St. Rank held Psyence Biomedical as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.